The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip
- PMID: 9263139
The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip
Abstract
Objective: To investigate the association of C-reactive protein (CRP) with symptoms of clinical disease and demographic factors in osteoarthritis (OA). In addition, to compare CRP with erythrocyte sedimentation rate (ESR) in their ability to associate with osteoarthritic symptoms and features.
Methods: A total of 655 consecutive clinic patients with OA of the knee or hip underwent a rheumatic disease examination, completed a clinical health assessment questionnaire (CLINHAQ), and had laboratory tests performed, including hemoglobin, CRP, and ESR.
Results: The median value of CRP was 5.9 micrograms/ml. CRP was significantly associated with functional disability, joint tenderness, pain, fatigue, global severity, and depression. In addition, correlations were noted for body mass index (BMI) and sex. ESR, by contrast, was unassociated with clinical signs or symptoms except for a weak association with functional disability. The best explanatory multiple regression model for CRP in OA includes BMI, functional disability, and joint tenderness count (R-squared 0.159).
Conclusion: CRP is elevated in OA compared to healthy individuals, and is correlated with rheumatic disease signs and symptoms, including HAQ disability, joint count, and pain. The associations, not seen with ESR, appear to be real, but are not strong. An inflammatory component associated with OA can be detected in the serum.
Similar articles
-
Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.Ital J Biochem. 2005 Sep-Dec;54(3-4):248-57. Ital J Biochem. 2005. PMID: 16688934
-
Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.J Rheumatol. 1997 Aug;24(8):1477-85. J Rheumatol. 1997. PMID: 9263138
-
Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.J Rheumatol. 2001 Jan;28(1):41-6. J Rheumatol. 2001. PMID: 11196541
-
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.J Rheumatol. 2007 Jun;34(6):1432-5. J Rheumatol. 2007. PMID: 17552070
-
Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease.Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):7-17. Epub 2019 Oct 14. Clin Exp Rheumatol. 2019. PMID: 31621569 Review.
Cited by
-
Determinants of pain in patients with symptomatic knee osteoarthritis.Caspian J Intern Med. 2016 Summer;7(3):153-161. Caspian J Intern Med. 2016. PMID: 27757198 Free PMC article. Review.
-
Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate.Rheumatol Int. 2013 May;33(5):1259-64. doi: 10.1007/s00296-012-2538-6. Epub 2012 Nov 4. Rheumatol Int. 2013. PMID: 23124693
-
No association between markers of inflammation and osteoarthritis of the hands and knees.J Rheumatol. 2011 Aug;38(8):1665-70. doi: 10.3899/jrheum.100971. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572158 Free PMC article.
-
Correlation between sialic acid levels in the synovial fluid and the radiographic severity of knee osteoarthritis.Exp Ther Med. 2014 Jul;8(1):255-259. doi: 10.3892/etm.2014.1679. Epub 2014 Apr 14. Exp Ther Med. 2014. PMID: 24944631 Free PMC article.
-
Nothing Boring About Boron.Integr Med (Encinitas). 2015 Aug;14(4):35-48. Integr Med (Encinitas). 2015. PMID: 26770156 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous